The E3 Ligase RNF8 Promotes Ubiquitination and Degradation of ChREBPα During Liver Stress Response
The FASEB Journal · 2026
DOI: 10.1096/fj.202600106r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Yuee Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Ubiquitination, Ubiquitin-Protein Ligases, Liver, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM), Division of Diabetes, Endocrinology, and Metabolic Diseases.
Abstract (Originalsprache)
As the most common chronic liver disease, MASLD can progress to metabolic dysfunction‐associated steatohepatitis (MASH) driven by accumulated metabolic and inflammatory stresses. We previously reported that liver ChREBPα protein is markedly downregulated in mouse models of diet‐induced MASH and hepatotoxin‐induced liver injury. Yet the impact of stress pathways on hepatocyte ChREBPα proteolysis has not been examined. Here, we show that a combined metabolic (palmitate, PA) and inflammatory (TNFα) stress signal promotes ubiquitination and proteasome‐mediated degradation of ChREBPα in hepatocytes. More importantly, we identify the stress‐induced E3 ligase RNF8 as interacting with and promoting ChREBPα ubiquitination and degradation in a JNK2‐dependent manner. In vivo, acute depletion of JNK2 or RNF8 stabilizes ChREBPα in mouse liver, increases some but not all ChREBPα transcriptional targets, and reduces diet‐induced liver steatosis, inflammation, and fibrosis. Overall, our findings reveal the biochemical machinery underlying stress‐induced ChREBPα proteolysis and suggest that targeting RNF8‐mediated ChREBPα ubiquitination could be a new strategy for treating MASH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
- Caswell Diabetes Institute, University of Michigan Medical School, Ann Arbor, Michigan, USA.
- Department of Nephrology, The First Affiliated Hospital of Kuming Medical University, Yunnan Province, P. R. China.
- Department of Infectious Diseases, the Second Xiangya Hospital, Central South University, Changsha, Hunan Province, P. R. China.
- Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha, Hunan Province, P. R. China.
- Neurosciences Graduate Program, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
ORCID-Profile: Xin Tong
Förderung
- HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM)
- Division of Diabetes, Endocrinology, and Metabolic Diseases
Zitieren
APA
Zhao, Y., Wang, S., Zhang, J., Cooke, S., Zhang, G., Zhao, Z., Oh, J., Tong, X., & Yin, L. (2026). The E3 Ligase RNF8 Promotes Ubiquitination and Degradation of ChREBPα During Liver Stress Response. The FASEB Journal. https://doi.org/10.1096/fj.202600106r
Vancouver
Zhao Y, Wang S, Zhang J, Cooke S, Zhang G, Zhao Z, et al. The E3 Ligase RNF8 Promotes Ubiquitination and Degradation of ChREBPα During Liver Stress Response. The FASEB Journal. 2026. doi:10.1096/fj.202600106r
BibTeX
@article{Zhao2026,
author = {Zhao, Yuee and Wang, Sujuan and Zhang, Jian and Cooke, Sarah and Zhang, Gary and Zhao, Zifeng and Oh, Joon and Tong, Xin and Yin, Lei},
title = {The E3 Ligase RNF8 Promotes Ubiquitination and Degradation of ChREBPα During Liver Stress Response},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202600106r}
}
EUVIMED